A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors.
about
Activin receptor-like kinases: a diverse family playing an important role in cancerPhase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.Tumor angiogenesis revisited: Regulators and clinical implications.Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.Academic Cancer Center Phase I Program Development.Reduced activin receptor-like kinase 1 activity promotes cardiac fibrosis in heart failure.
P2860
A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A Phase I Study of the Anti-Ac ...... ts with Advanced Solid Tumors.
@ast
A Phase I Study of the Anti-Ac ...... ts with Advanced Solid Tumors.
@en
type
label
A Phase I Study of the Anti-Ac ...... ts with Advanced Solid Tumors.
@ast
A Phase I Study of the Anti-Ac ...... ts with Advanced Solid Tumors.
@en
prefLabel
A Phase I Study of the Anti-Ac ...... ts with Advanced Solid Tumors.
@ast
A Phase I Study of the Anti-Ac ...... ts with Advanced Solid Tumors.
@en
P2093
P1476
A Phase I Study of the Anti-Ac ...... ts with Advanced Solid Tumors.
@en
P2093
Andrej Lyshchik
Antonello Abbattista
Corrado Gallo Stampino
Cristina Noberasco
Erjan Wang
Hossein Borghaei
Jordan D Berlin
Laura W Goff
Marina Carpentieri
Roger B Cohen
P304
P356
10.1158/1078-0432.CCR-15-1622
P407
P577
2015-12-11T00:00:00Z